Testing effectiveness (Phase 2)Study completedNCT02204787What this trial is testingTreatment of Negative Symptoms and SchizophreniaWho this might be right forSchizophrenia University Hospital, Montpellier 60
Not applicableLooking for participantsNCT05866107What this trial is testingApp and Body Fat Scale in the Management of Overweight PatientsWho this might be right forSchizophreniaBipolar DisorderMetabolic Syndrome+1 more Capital Medical University 204
Post-approval studies (Phase 4)UnknownNCT05646264What this trial is testingA Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in SchizophreniaWho this might be right forSchizophreniaNegative Symptoms in Schizophrenia Shanghai Mental Health Center 220
Not applicableStudy completedNCT01028196What this trial is testingObservational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionWho this might be right forSchizophreniaSchizoaffective DisorderRecurrent Depression AstraZeneca 750
Post-approval studies (Phase 4)UnknownNCT00541554What this trial is testingReversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and DyslipidemiaWho this might be right forHyperprolactinemiaWeight GainDyslipidemia Genovate Biotechnology Co., Ltd.,
Very early researchUnknownNCT04533724What this trial is testingStudy on the Gut Microbial Mechanism of Negative Symptoms of SchizophreniaWho this might be right forNegative SymptomSchizophreniaAmisulpride+1 more Shanghai Mental Health Center 6
Not applicableStudy completedNCT00224380What this trial is testingMedication Adherence in Older Adults With Serious Mental IllnessWho this might be right forSchizophreniaBipolar DisorderDepression Dartmouth-Hitchcock Medical Center 72
Not applicableUnknownNCT03552237What this trial is testingEffect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia PatientsWho this might be right forSchizophreniaCentral Obesity TsaoTun Psychiatric Center, Department of Health, Taiwan 40
Not applicableUnknownNCT00645580What this trial is testingGenetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive FunctionWho this might be right forSchizophrenia Sha'ar Menashe Mental Health Center 15
Post-approval studies (Phase 4)UnknownNCT01968161What this trial is testingInvestigator Initiated Study - Asenapine Early PsychosisWho this might be right forSchizophrenia and Disorders With Psychotic FeaturesDisorders Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec 12
Not applicableStudy completedNCT00534222What this trial is testingUnraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine EffectWho this might be right forManiaSchizophrenia AstraZeneca 387
Large-scale testing (Phase 3)Study completedNCT00797277What this trial is testingIntramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaWho this might be right forSchizophreniaSchizoaffective DisorderAgitation National Taiwan University Hospital 67
Not applicableStudy completedNCT04325100What this trial is testingIntervention Targeting Motivational Negative SymptomsWho this might be right forSchizophreniaSchizo Affective DisorderBipolar Disorder+1 more University of Liege 13
Not applicableStudy completedNCT02183844What this trial is testingA System for Preference Assessment in Mental HealthWho this might be right forMental DisordersSchizophreniaOverweight+1 more University of California, Los Angeles 61
Large-scale testing (Phase 3)Ended earlyNCT00486798What this trial is testingFAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute PsychosisWho this might be right forPsychotic DisordersSchizophreniaBipolar Disorder AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT00044044What this trial is testingA Comparison of Study Drug With Placebo and Haloperidol in Patients With SchizophreniaWho this might be right forSchizophrenia Sumitomo Pharma America, Inc. 356
Testing effectiveness (Phase 2)Study completedNCT00616798What this trial is testingRO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.Who this might be right forSchizophrenia Hoffmann-La Roche 323
Post-approval studies (Phase 4)Study completedNCT00202293What this trial is testingComparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic FeaturesWho this might be right forBipolar DisorderSchizoaffective Disorder Melbourne Health 83
Not applicableStudy completedNCT03028545What this trial is testingRepresentations and Strategies for RecoveryWho this might be right forSchizophrenia, UndifferentiatedAnorexiaBipolar Disorders+1 more Hôpital le Vinatier 37
Not applicableStudy completedNCT04280367What this trial is testingLearning and Executive Function Disorders in Children and Psychosis Risk at Adult-ageWho this might be right forSchizophreniaLearning DisordersExecutive Function Disorders Assistance Publique - Hôpitaux de Paris 20